Indicative Announcement on Convening the 1st Extraordinary General Meeting in 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(600645)"Vcanbio Cell & Gene Engineering Corp., Ltd."Indicative Announcement on Convening the 1st Extraordinary General Meeting in 2026
Filed with SSE · Stock code 600645 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)Vcanbio Cell & Gene Engineering Corp., Ltd. on 6ix
Story so far
- (600645)"Vcanbio Cell & Gene Engineering Corp., Ltd."Announcement on Resolutions of the 3rd Extraordinary Meeting of the 12th Board of Directors
- (600645)"Vcanbio Cell & Gene Engineering Corp., Ltd."Notice on Convening the 1st Extraordinary General Meeting in 2026
- Announcement on Convening the 2025 Annual Performance Briefing
Earlier from Vcanbio Cell & Gene Engineering
- (600645)"Vcanbio Cell & Gene Engineering Corp., Ltd."Notice on Convening the 1st Extraordinary General Meeting in 2026
- (600645)"Vcanbio Cell & Gene Engineering Corp., Ltd."Announcement on Resolutions of the 3rd Extraordinary Meeting of the 12th Board of Directors
- (600645)"Vcanbio Cell & Gene Engineering Corp., Ltd."Announcement on Progress in Using Temporarily Idle Raised Funds for Cash Management
- (600645)"Vcanbio Cell & Gene Engineering Corp., Ltd."Announcement on Extension of the Raised Funds Investment Project "Development of Tumor Marker Diagnostic Reagents"
- (600645)"Vcanbio Cell & Gene Engineering Corp., Ltd."Announcement on Change of Certain Raised Funds Investment Projects and Implementation of Raised Funds Investment Projects via Providing Loans to Controlled Subsidiary with Raised Funds
Follow Vcanbio Cell & Gene Engineering into a list and get an email when it puts out news.
Follow Vcanbio Cell & Gene Engineering